FSD Pharma Inc (NASDAQ:HUGE) does about 2.77M shares in volume on a normal day but saw 10491866 shares change hands in the recent trading day. The company now has a market cap of 3.40M USD. Its current market price is $0.08, marking a decrease of -9.68% compared to the previous close of $0.09. The 52 week high reached by this stock is $1.68 whilst the lowest price level in 52 weeks is $0.09.
FSD Pharma Inc (HUGE) has a 20-day trading average at $0.1350 and the current price is -95.00% off the 52-week high compared with -9.29% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.1932 and its 200-day simple moving average is $0.6676. If we look at the stock’s price movements over the week, volatility stands at 23.08%, which decreases to 12.58% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 21.73 to suggest the stock is oversold.
The consensus objective for the share price is $2.60, suggesting that the stock has a potential upside of 96.92% over the period.
FSD Pharma Inc (HUGE) stock is down -42.23% over the week and -40.89% over the past month. Its price is -90.87% year-to-date and -93.59% over the past year.
The stock last released its quarterly earnings report for quarter ended 3/31/2024, with the company’s earnings per share (EPS) of -0.03 above consensus estimates by 0.11. The company’s next earnings report forecasts estimating quarterly EPS at -0.06 and -0.22 for whole year. Expected sales for next quarter are $710k, which analysts say will come at $950k for the current fiscal year and next year at $8.68M. In addition, estimates put the company’s current quarterly revenue at an average of $710k.
To reach the target analysts have set, the stock logically needs to grow 96.92 percent from here.
The company has a return on investment of -84.59% and return on equity of -61.89%. The beta has a value of 0.59. Price to book ratio is 0.28.
